We are live on ! Find out more
OGEN icon

Oragenics

23 hedge funds and large institutions have $8.27M invested in Oragenics in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

116% more capital invested

Capital invested by funds: $3.83M → $8.27M (+$4.44M)

100% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 4

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

15% more funds holding

Funds holding: 2023 (+3)

0% less ownership

Funds ownership: 0.01%0% (-0%)

Holders
23
Holders Change
+3
Holders Change %
+15%
% of All Funds
0.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
8
Reduced
4
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
WWM
26
Wolff Wiese Magana
California
$1K +$1.82K +1 New
IAA
27
Independent Advisor Alliance
North Carolina
-$1.89M -2,333 Closed
Squarepoint
28
Squarepoint
New York
-$13K -16 Closed
GPFA
29
Game Plan Financial Advisors
Ohio
-$5K -6 Closed
UBS Group
30
UBS Group
Switzerland
-$5K -6 Closed

OGEN Hedge Fund Activity: Q1 2021 in Review

23 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q1 2021, worth a combined $8.27M — up 116% from $3.83M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new OGEN positions and 5 closed out — a net gain of 3 holders — while 8 added to existing stakes and 4 trimmed.

The largest buyer was Vanguard Group, adding an estimated $3.12M. The largest seller was Independent Advisor Alliance, exiting entirely with an estimated $1.89M sold.

  • 23 institutional investors held Oragenics (OGEN) as of Q1 2021, up from 20 in Q4 2020.
  • Funds reported $8.27M of Oragenics stock for Q1 2021, up 116% quarter-over-quarter.
  • 8 funds opened new Oragenics positions in Q1 2021 and 5 closed out, a net change of +3 holders.
  • The largest Oragenics buyer in Q1 2021 was Vanguard Group, an estimated $3.12M added.
  • The largest Oragenics seller in Q1 2021 was Independent Advisor Alliance, an estimated $1.89M sold.

Based on aggregated 13F filings for Q1 2021.